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Abstract

*Correspondence to:

Despite substantial progress in neonatal care over the past two decades leading to improved survival of
extremely premature infants, extreme prematurity continues to be associated with long term neurodevelopmental impairments. Cerebral white matter injury is the predominant form of insult in preterm brain
leading to adverse neurological consequences. Such brain injury pattern and unfavorable neurologic sequelae is commonly encountered in premature infants exposed to systemic inflammatory states such as
clinical or culture proven sepsis with or without evidence of meningitis, prolonged mechanical ventilation,
bronchopulmonary dysplasia, necrotizing enterocolitis and chorioamnionitis. Underlying mechanisms
may include cytokine mediated processes without direct entry of pathogens into the brain, developmental
differences in immune response and complex neurovascular barrier system that play a critical role in regulating the cerebral response to various systemic inflammatory insults in premature infants. Understanding
of these pathologic mechanisms and clinical correlates of such injury based on serum biomarkers or brain
imaging findings on magnetic resonance imaging will pave way for future research and translational therapeutic opportunities for the developing brain.
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Introduction

Premature birth occurs in 10% of pregnancies in the United
States (Centers for Disease Control and Prevention (CDC),
2015) and 5–18% of pregnancies across 184 countries worldwide (Blencowe et al., 2012). Neurodevelopmental impairment such as cerebral palsy (prevalence 5–10%) and cognitive and behavioral deficits (prevalence 40–50%) are a major
cause of morbidity in survivors of prematurity (Gargus et al.,
2009; Stoll et al., 2010). Despite major progress in neonatal
care over the last two decades and improved survival rates
for extremely premature infants (born at gestational age ≤ 28
weeks), premature infants continue to contribute inordinately to the burden of early childhood morbidity and long term
neurodevelopmental disability (Saigal and Doyle, 2008). The
goals of this article are to provide a brief review of current
literature with respect to the contribution of inflammatory
pathways in preterm infant brain injury risks and outcomes.

The Association between Perinatal
Inflammatory States and Neurodevelopmental
Impairment

The profound vulnerability of the developing brain to cumulative insults by inflammatory, hypoxic-ischemic and metabolic
processes in the perinatal period is a primary component of
brain injury in prematurity (Volpe, 2009). Infections, whether
congenital or iatrogenic, are a frequent complication in premature infants. The risk of developing serious life threatening
blood stream infection increases with decreasing birth weight
890

and gestational age. In addition, a considerable number
(25–60%) of extremely premature infants develop at least one
invasive bacterial infection during their neonatal intensive
care hospitalization, with recurrent infections being common
among many premature neonates (Stoll et al., 2010).
Chorioamnionitis diagnosed clinically or histologically is
an important cause of premature birth. Presence of histologic evidence of chorioamnionitis has been shown in 65% of
placentae in deliveries done at 23–24 weeks of gestational age
and can be detected in 30% placentae delivered at 29 weeks
of gestation (Lahra and Jeffery, 2004). Presence of intrauterine infection does not always translate to early onset sepsis
in preterm neonates. However, it could lead to activation of
a fetal inflammatory response which may be associated with
cerebral white matter injury and later neurodevelopmental
impairment (Wu and Colford, 2000; Yoon et al., 2003). Recent
reports have demonstrated that any form of systemic inflammation such as clinical sepsis or culture proven sepsis, meningitis with or without bacteremia, bronchopulmonary dysplasia
(BPD) and necrotizing enterocolitis (NEC) were all associated
with impaired growth and increased risk of adverse neurologic
sequelae in premature infants (Stoll et al., 2004; Schlapbach
et al., 2011; Mitha et al., 2013). Interestingly, it has also been
reported that late onset sepsis in preterm infants and recurrent
neonatal blood stream infections even without evidence of
meningitis are associated with increased risk of progressive cerebral white matter injury and acute changes in cerebral function indicated by burst suppression pattern on electrographic
studies (Glass et al., 2008; Helderman et al., 2010), pointing to
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systemic inflammation from the blood stream infection likely
contributing to collateral brain damage.
BPD, which is characterized by arrested alveolar growth
and lung inflammation defined as supplemental oxygen
administration at 36 weeks of postmenstrual age for premature infants < 32 weeks of gestation, is known to have a high
incidence (55%) in infants born at or < 26 weeks in a recent
report of morbidities in prematurity (Stoll et al., 2015) that
continues to increase as more extremely low birth weight infants weighing less than 1,000 g (ELBW) are surviving. BPD
is a notable precedent of impaired neurodevelopmental and
adverse motor outcomes that is independently associated
with cognitive impairment in ELBW infants (Natarajan et
al., 2012). In another recent cohort, prolonged dependence
on mechanical ventilation at 36 weeks of postmenstrual age,
often seen in infants with severe BPD, substantially increased
the risk of quadriparesis and diparesis by 6 fold and 4 fold
respectively (Van Marter et al., 2011).
Significant neurologic, cognitive and behavioral problems
are common sequelae of serious central nervous system (CNS)
lesions of prematurity such as severe grade intraventricular
hemorrhage with post hemorrhagic ventricular dilatation,
hemorrhagic parenchymal infarction or cystic periventricular
leukomalacia (PVL). However, the majority of premature infants exhibiting neurocognitive deficits do not manifest such
patterns of injury, suggesting that there may be other alterations, insults and remodeling in the developing premature
brain resulting in more diffuse injury. Serial brain magnetic
resonance imaging (MRI) data from a cohort of 119 premature babies born less than 30 weeks of gestation showed that
at least 50% of babies manifest some degree of cerebral white
matter injury which accounts for the majority of neurological
deficits seen in survivors of prematurity (Dyet et al., 2006).
Such cerebral white matter injury characterized by loss of
myelination of oligodendrocytes is the predominant form of
brain injury seen in premature brain and is associated with
high incidence of neurodevelopmental impairment (Khwaja
and Volpe, 2008). The exclusive developmental anatomy of
the premature brain and its exposure to the abnormal ambience of extrauterine preterm life makes it particularly vulnerable to damage. Systemic inflammatory insults, such as those
described in the previous paragraphs, are common phenomena in premature babies. Systemic inflammation activates a
cascade of pro-inflammatory cytokines in circulation which
leads to activation of microglia locally in the brain along with
free radical attack by reactive oxygen and nitrogen species
resulting in maturation dependent cell death and apoptosis of
neural cells. Further definition of mechanisms that cause such
collateral brain injury will hopefully lead to prevention strategies in these settings of systemic inflammatory states.

The Impact of Systemic Inflammation on
Premature Brain: Potential Mechanisms of
Brain Injury

Cytokine driven tissue injury
The pathophysiology of systemic inflammation in a preterm
neonate involves a complex interplay between innate host
defense and an impaired adaptive immune response of a developing fetus challenged too early to extrauterine life with

precipitous exposures to various new antigens they are not
prepared to respond against. Microorganisms express preserved sequences of pathogen associated molecular patterns
(PAMPs) such as lipopolysaccharides (LPS) or double stranded RNA which can be recognized by human cells through
pattern recognition receptors such a Toll-like receptors (TLR)
in clinical conditions such as sepsis and bacteremia (Wynn
and Levy, 2010). A cascade of reactions are generated when
the neonate’s immune system recognizes such pathogens that
ultimately lead to activation of pro-inflammatory cytokines
and chemokines such as tumor necrosis factor-α (TNF-α),
interleukin-1β (IL-1β) and IL-6 (Janeway and Medzhitov,
2002; Weighardt and Holzmann, 2007). The adaptive immune
response in premature babies is unique because compared to
adults, there is dampened production of T-helper 1 (Th1) polarizing cytokines such as TNF-α, IL-1β, interferon-γ (IFN-γ)
and IL-12 and robust production of T-helper 2 (Th2) polarizing cytokines leading to increased susceptibility to infections
(Sadeghi et al., 2007; Wynn et al., 2008). This in turn incites
dysregulation of inflammatory reactions of the premature infant leading to a pro-inflammatory state.
Cytokines may gain access to the CNS by blood borne
routes or by endogenous production from immune cells,
brain endothelial cells, microglia, astrocytes and neurons
(Sebire et al., 1993; Banks, 2005). Elevated levels of circulating cytokines in premature neonates were evidenced in cord
blood, amniotic fluid, cerebrospinal fluid and cerebral parenchyma of infants diagnosed with inflammation related white
matter lesions speaking to potentially direct damage by the
systemic cytokines (Yoon et al., 1996, 1997; Martinez et al.,
1998). While there is no clear correlation between cytokine
profile in plasma and cerebrospinal fluid (CSF) of preterm
neonates in response to systemic inflammation or infection,
systemic inflammation certainly appears to be associated with
premature brain injury (Ellison et al., 2005).
Cytokines may also activate local immune cells in the premature brain. Astrocytes and microglia are the two primary
CNS cell types which are involved in intracerebral immune
interactions by secretion of cytokines and chemokines. Astrocytes, microglia and oligodendrocyte progenitor cells also
express and are activated by cytokine specific receptors such
as IL-1β and IFN-γ receptors (Vela et al., 2002). Various
cytokines particularly TNF-α and IFN-γ have been isolated
directly in neonatal PVL and white matter lesions expressed
specifically in microglia/macrophages and astrocytes respectively (Kadhim et al., 2001; Folkerth et al., 2004) with degree
of expression correlating with severity of oxidative damage
on histopathological studies (Folkerth et al., 2004). Immunohistochemistry staining of preterm infant autopsy brain
specimens have demonstrated oxidative and nitrative damage in primarily progenitor premyelinating oligodendrocytes
in white matter lesions of the immature brain (Haynes et al.,
2003; Back et al., 2005). CSF data followed in a longitudinal
study of premature very low birth weight (VLBW) infants
also support the role of oxidative damage and elevated levels of oxidative products in CSF of preterm infants with
brain MRI evidence of white matter injury at term gestation
compared to premature infants without evidence of white
matter lesions on MRI (Inder et al., 2002). The extent of the
involvement of local microglia in such inflammation associated preterm brain injury may be related to its unique de891
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velopmental or maturation dependent location. Recent brain
autopsy studies have ascertained presence of microglia in the
human forebrain starting from 16-22 weeks of gestation with
heavy localization in the cerebral white matter (Rezaie et al.,
2005; Monier et al., 2006). The density of microglia reaches
its peak in the third trimester which is the period for intense
susceptibility for the preterm brain to develop white matter
injury with significant decline in density at term gestation
(Billiards et al., 2006).
The current evidence and observations suggest that an active fetal cerebral immune response resulting in excitotoxicity and free radical attack, secondary to systemic inflammatory insult rather than actual passage of pathogens into the
developing CNS is likely the key pathogenesis for cerebral
damage in premature infants (Figure 1).
Alteration of blood-brain barrier (BBB) function
The BBB and blood cerebrospinal fluid barrier (BCSFB) are
two major interfaces which play a critical role in separating
the brain parenchyma from systemic circulation, thereby preserving and maintaining a normal physiologic environment
paramount for optimal brain growth and function. The BBB
is a highly selective diffusion barrier composed of specialized
endothelial cells interconnected by an elaborate network of
complex tight junction proteins in a basal lamina containing
pericytes and perivascular antigen presenting cells enveloped
by perivascular astrocytes (Abbott et al., 2010). Contrary to old
reports of BBB being under developed in fetuses and neonates,
the selective function of the BBB is effective from very early
stages of brain development. It is demonstrated by exclusion
of passage of proteins and small lipid insoluble molecules between systemic circulation and brain extracellular fluid with a
characteristic maturation dependent decline in permeability as
the brain develops (Saunders et al., 1999, 2000). Animal studies in fetal and newborn rats and opossums showed increased
permeability of the BBB (not BCSFB) to plasma proteins specifically acute phase reactants, IL-1β and TNF-α in response to
LPS induced systemic inflammation during a restricted period
of postnatal brain development in both species. This was determined immunocytochemically by the presence of related proteins in surrounding cerebral blood vessels and brain parenchyma involving particularly the cerebral white matter (Stolp
et al., 2005) again highlighting the location specific nature of
perinatal brain injury in association with systemic inflammation in prematurity.
The BBB is a dynamic regulatory structure the organization
or function of which may be altered by circulating cytokines,
chemokines or chemical secreted by cells constituting the BBB
itself. Agents associated with altered BBB integrity in adults
with neurodegenerative diseases or stroke are bradykinin,
histamine, serotonin, glutamate, adenosine, platelet activating
factor, prostaglandins, leukotrienes, interleukins (IL-1β, IL1α, IL-6), TNF-α, macrophage inhibitory proteins, matrix
metalloproteinases, free radicals and nitric oxide, many of
which are upregulated during and after infections and systemic inflammatory states (Abbott et al., 2006). Disordered
function of BBB may be a result of systemic or locally secreted
cytokines altering saturable transporter mechanisms (Xaio et
al., 2001) or adenosine trisphosphate dependent efflux pump
activity of the BBB (Bauer et al., 2007) and not truly compro892

mising its structural integrity. Hence it is possible that localized or systemic inflammatory response in fetuses or premature neonates remote from the CNS may result in increased
cytokine admittance to the CNS by disruption of BBB/BCSFB
function. Since there is some indication from animal studies
that such alteration of BBB may be brain maturation or location specifically white matter related, identification of periods
in brain development when the fetal or premature CNS is
most vulnerable to inflammatory insult induced damage is of
paramount importance to determine the therapeutic window
for any pharmacologic intervention against such brain injury.
Impaired cerebrovascular autoregulation
It is unclear what role hypotension, cardiovascular instability, and/or impairment of cerebrovascular autoregulation
in response to systemic cytokine surge and brain ischemia
play in sepsis and fetal inflammatory states. Many premature
infants suffer from hypotension and need inotropic support
during systemic inflammatory conditions such as sepsis and
necrotizing enterocolitis (NEC). Interestingly, decreased
systemic blood pressure may not correlate with decreased
cerebral blood flow (Volpe, 2008) and pressure passive cerebral circulation is common in sick premature babies (Soul
et al., 2007). However, cytokinemia associated with systemic
inflammatory states and infection in premature infants may
blunt cerebral vascular auto regulatory mechanisms in the
developing brain and augment an otherwise weak hypoxic-ischemic insult to a potent damaging one (Ikeda et al.,
2004; Larouche et al., 2005; Wang et al., 2007).

Diagnostic Imaging and Biomarkers of
Perinatal White Matter Injury in Premature
Infants

Biomarkers with accurate diagnostic and prognostic potential are needed for differentiating between infants who have
significant neuroinflammation and white matter injury associated with chances of permanent sequelae from the ones
who might benefit from therapeutic interventions. The Extremely Low Gestational Age Newborn (ELGAN) study for e
newborns at extremely low gestational age demonstrated that
serial measurements of plasma levels of vascular endothelial growth factor receptor 1, serum amyloid A, macrophage
inflammatory protein 1β on day of life 1 and IL-8 on day of
life 7 in extremely premature infants were associated with increased risk ventriculomegaly and diffuse white matter changes on brain MRI (Leviton et al., 2011). Even though plasma
cytokine levels for prediction of white matter injury seems to
have diagnostic value, earlier studies have failed to establish a
correlation between plasma and CSF cytokine levels further
implying that certain cytokines such as IL-8 may achieve
higher levels in CSF than in plasma which may be more predictive of MRI-defined white matter injury related to systemic
infection or inflammation in premature newborns (Ellison
et al., 2005). Hence, overt reliance on plasma cytokine levels
may delay or prevent early recognition of neurological consequences of systemic inflammatory states. Currently, cytokines
are not routinely measured in a neonatal intensive care unit
(NICU) setting in preterm inflammatory conditions and will
necessitate cost effective standardized validated assay meth-
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ods prior to integration into standard NICU practice.
The use of neonatal brain MRI is a safe technique to study
in vivo brain development and has lead way for research in sequelae of premature birth and prematurity related comorbidities on the developing brain. Traditionally brain ultrasound
imaging has been used routinely in NICU practice for serial
monitoring of germinal matrix hemorrhage, intraventricular hemorrhage and its complications and detection of PVL.
Although these are well recognized causes of motor and neurodevelopmental impairment in premature babies these are
not the predominantly noted brain lesions on MRI imaging
of premature babies. In a cohort of 119 VLBW babies, only
2 infants were noted to have evidence of PVL on brain MRI
whereas 26 babies had punctate lesions in the white matter
and 70 had diffuse excessive high signal intensity (DEHSI)
at term equivalent age (Dyet et al., 2006). The etiology and
clinical relevance of these newly recognized brain lesions using advanced MRI techniques are still to be elucidated. Some
authors have hypothesized that such punctate white matter
lesions and DEHSI in preterm population represent activated
microglia and hence may indicate an association with sepsis,
systemic infections or chronic lung disease of prematurity
(Anjari et al., 2009; Rutherford et al., 2010).
Some authors have reported long term follow up studies on cohorts of premature VLBW infants to determine if
moderate to severe white matter abnormalities and DEHSI
noted on brain MRI are anatomic antecedents of neurological impairments in children born prematurely. In a study of
167 very premature infants (born < 30 weeks of gestation),
the presence of any white matter abnormality or moderate
to severe white matter abnormalities on MRI were noted
to be more sensitive although less specific than ultrasound
findings in identifying children who had severe neurodevelopmental impairments in long term follow up at 2 years
(corrected for prematurity) age (Woodward et al., 2006). The
presence of moderate to severe white matter abnormalities in
this study was predictive of severe psychomotor delay (10%),
cerebral palsy (10%), cognitive delay (25%) on Bayley scales of
Infant Development-II and neurosensory impairment (11%)
independently of abnormalities on cranial ultrasound imaging.
Another smaller study which looked at diffusion weighted imaging on 38 VLBW infants at term equivalent age found that
the presence of DEHSI was strongly associated with lower developmental quotient at 2 years of age (Krishnan et al., 2007).
In another cohort of 68 preterm infants who had confirmed
sepsis and or NEC, significant white matter abnormalities were
noted on brain MRI at term and those infants had poorer psychomotor development at 2 years of age compared to age and
gestation matched controls without sepsis and or NEC (Shah
et al., 2008). Evidence of thalamic atrophy, loss of myelination
especially in posterior limb of internal capsule, and overall loss
in cortical white matter on MRI imaging are strong predictors
of development of cerebral palsy and inability of independent
walking in preterm infants (Inder et al., 1999; Cowan and de
Vries, 2005; Ricci et al., 2006).
It is noteworthy that some preterm born children with
white matter abnormalities on MRI were free of severe impairments and had normal motor development at 2 years of
age in both studies (Woodward et al., 2006; Krishnan et al.,
2007) which accentuates that obtaining brain MRI at term
equivalent age on prematurely born babies may serve as an

important screening tool for closer monitoring of babies at
highest risk of neurodevelopmental impairments but also
that not all ominous brain MRI findings will translate to severe neurodevelopmental problems in early childhood. This
highlights the influence of genetics and home environment
in overcoming the aftermath of prematurity and systemic
inflammation related comorbidities and determining long
term neurodevelopmental outcomes.

Potential Therapeutic Interventions:
Directions of Future Research

All novel interventions and therapies in neonatology must
go through rigorous evaluation for unexpected long term adverse effects prior to their application in routine practice as the
vulnerable population of premature babies is in critical phase
of organ development and maturation. Even though experimental animal data is available for several strategies targeting
amelioration of systemic inflammation induced cerebral injury, their application in routine patient management has so far
been limited. Corticosteroids are potent anti-inflammatory
agents and dexamethasone use in treatment and prevention of
chronic lung disease of prematurity is a well prevalent practice (Doyle et al., 2010). Corticosteroids have been shown to
modulate chorioamnionitis induced fetal inflammatory state
in fetal ovine model (Wolfe et al., 2013), however the concern
of significantly increased risk of cerebral palsy and adverse
neurodevelopmental outcomes associated with prolonged
postnatal use of corticosteroids particularly dexamethasone in
preterm neonates (Wilson-Costello et al., 2009) has prohibited
its frequent clinical use.
N-acetylecysteine has shown promise as a free radical scavenger and antioxidant that has successfully prevented LPS and
fetal inflammation-induced degeneration of oligodendrocyte
progenitor cells and myelination defects by attenuating intracerebral inflammatory reaction and TNF, IL-1 and inducible nitric oxide synthase expression in mouse models (Paintlia et al.,
2004; Chang et al., 2011; Beloosesky et al., 2013). Minocycline
has anti-apoptotic, antioxidant and anti-inflammatory properties in animal models by diminishing microglial activation and
maintaining BBB integrity in systemic inflammation associated
cerebral insult (Stolp et al., 2007). Pentoxifylline, a phosphodiesterase inhibitor that increases intracellular cyclic adenosine
monophosphate levels has protective effects in LPS-induced
white matter injury in a rat model of PVL (Dilek et al., 2013).
The drug has a favorable clinical profile in premature neonates
and is currently being studied as an adjunct therapy to decrease
mortality and morbidities from sepsis and NEC in premature
neonates (Pammi and Haque, 2015).
Studies targeting BBB dysfunction are also being explored.
Recently, elevated expression of tight junction proteins such
as claudin-3, 5 and occludins were noted after treatment
with simvastatin and low molecular weight heparin in animal models of sepsis resulting in improved selective function
and decreased permeability of the BBB (Li et al., 2015; Yang
et al., 2015). Matrix metalloproteinase-2, 9 inhibitors have
been reported to reverse increases in BBB permeability and
decrease IL-6 expression in animal model of sepsis related
BBB dysfunction (Dal-Pizzol et al., 2013). Various immunological interventions are additionally the subject of ongoing
research efforts. Systemic administration of a synthetic im893
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Common preterm infant morbidities

- Chorioamnionitis
- Infection/sepsis
- Bronchopulmonary dysplasia/Chronic lung inflammation
- Necrotizing enterocolitis
- Surgical intervention

Systemic inflammation

Cytokines

Altered BBB
function

Microglia
activation

Impaired cerebral
autoregulation

Pre-OL injury
White matter
damage

Neurodevelopmental impairment

Figure 1 Various mechanisms causing injury to the developing
brain in systemic inflammatory state.

mune regulator protein 1018 (innate defense regulator peptide) led to protection against white matter injury in a LPS
and hypoxia-ischemia induced perinatal brain injury model
in mice (Bolouri et al., 2014).
Separate from small molecule or protein therapeutics to
affect preterm infant brain injury are several recent preclinical studies, and some ongoing clinical trials, exploring
the potential of cell-based treatments (Titomanlio et al.,
2011; Verina et al., 2013; Chicha et al., 2014; Mitsialis and
Kourembanas, 2016). Most of these studies involve the
administration of live cells with progenitor/stem-like properties, with the guise that these cells can multiply to grow
new tissues replacing the cells damaged from perinatal
insults, or (more likely) secrete beneficial factors in specific
brain regions and enhance regional growth in a developing
organ (Lee et al., 2010; Donega et al., 2015). In many cases
the preclinical studies support the potential benefits of this
approach, with the most compelling effects being related
to direct injections of cell preparations into the lesion (van
Velthoven et al., 2010a; Mitsialis and Kourembanas, 2016).
Intranasal delivery has also shown some moderate promise
(van Velthoven et al., 2010b; Donega et al., 2015). Most data
strongly support the ‘paracrine-benefit’ mechanism, wherein the implanted cells release beneficial factors and enhance
tissue repair (van Velthoven et al., 2010a; van Velthoven et
al., 2013; Park et al., 2015). Although majority of this investigation has been done in hypoxic ischemic perinatal brain
injury setting the final pathogenesis of brain damage in both
hypoxic ischemic brain injury and systemic inflammatory
perinatal insult induced brain injury include excitotoxicity
and oxidative damage in which stem-cell based therapies
may represent the much awaited answer in the developing
premature neonate. Studies in this setting have not as yet
investigated the interactions of these cells with inflammatory pathways that can contribute to tissue remodeling. This
field is in its very early stages and although there is great
potential for benefit and somewhat promising results thus
far, some important hurdles include reliable tissue delivery
894

and regulatory challenges in demonstrating long term clinical benefits and avoiding long term disease risks (especially
cancer, etc.).
Collectively it is clear that there are several therapeutic
strategies that may have real value in reducing the neurodevelopmental morbidities and major costs associated with
preterm infant brain injury. For many of these strategies there
is ample experimental data to support a conceivable effort
toward clinical investigations and make a substantial impact.
Given the high prevalence of preterm infant brain injury, and
its often-devastating consequences, the diligent pursuit of
newer therapies to enhance outcomes is certainly warranted.

Conclusion

Brain injury in preterm infants is a major medical problem
and health care cost worldwide; inflammatory mechanisms
are very likely contributors to nearly all settings and etiologies. Pertinent knowledge gaps still exist in our detailed understanding of underlying cytokine mediated mechanisms,
developmental differences in immune response and complex
neurovascular barrier system that play a critical role in in
regulating the cerebral response to systemic inflammatory
conditions in premature human neonates. A better understanding of the dual role of cytokines and balance between
pro- and anti-inflammatory mediators and its role in brain
development and maturation is needed to completely appreciate the long term neurodevelopmental consequences
in this susceptible population. A valid diagnostic cytokine
profile needs to be designed for biomarkers of perinatal
brain injury for evaluation in a clinical setting of neonatal
sepsis, NEC or other systemic inflammatory state. From
currently available studies white matter abnormality on MRI
seems to be the anatomic substrate or antecedent for future
progression to adverse neurodevelopment in a background
of prematurity and systemic inflammation. Hence, advanced
brain MR imaging should be considered as part of routine
care for every premature baby exposed to systemic inflammatory conditions in their neonatal course and not just as an
adjuvant evaluation reserved for babies with severe abnormalities on cranial ultrasound imaging at term equivalent
age. There is now increasing clinical and experimental evidence that systemic inflammatory pathways can damage the
preterm brain even in absence of direct entry of infectious
agent to the CNS. Given the high rate of preterm birth and
huge prevalence of prematurity related inflammatory states
there is a dire need for development of novel translational
approaches to alleviate long term neurodevelopmental consequences in this highly vulnerable population.
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